Harada, Y.; Tominaga, M.; Iitoh, E.; Kaieda, S.; Koga, T.; Fujimoto, K.; Chikasue, T.; Obara, H.; Kakuma, T.; Ida, H.;
et al. Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy. J. Clin. Med. 2022, 11, 1925.
https://doi.org/10.3390/jcm11071925
AMA Style
Harada Y, Tominaga M, Iitoh E, Kaieda S, Koga T, Fujimoto K, Chikasue T, Obara H, Kakuma T, Ida H,
et al. Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy. Journal of Clinical Medicine. 2022; 11(7):1925.
https://doi.org/10.3390/jcm11071925
Chicago/Turabian Style
Harada, Yumi, Masaki Tominaga, Eriko Iitoh, Shinjiro Kaieda, Takuma Koga, Kiminori Fujimoto, Tomonori Chikasue, Hitoshi Obara, Tatsuyuki Kakuma, Hiroaki Ida,
and et al. 2022. "Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy" Journal of Clinical Medicine 11, no. 7: 1925.
https://doi.org/10.3390/jcm11071925
APA Style
Harada, Y., Tominaga, M., Iitoh, E., Kaieda, S., Koga, T., Fujimoto, K., Chikasue, T., Obara, H., Kakuma, T., Ida, H., Kawayama, T., & Hoshino, T.
(2022). Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy. Journal of Clinical Medicine, 11(7), 1925.
https://doi.org/10.3390/jcm11071925
